ATE319430T1 - Verfahren zur herstellung einer festen oralen dosierungsform von desmopressin - Google Patents

Verfahren zur herstellung einer festen oralen dosierungsform von desmopressin

Info

Publication number
ATE319430T1
ATE319430T1 AT03029897T AT03029897T ATE319430T1 AT E319430 T1 ATE319430 T1 AT E319430T1 AT 03029897 T AT03029897 T AT 03029897T AT 03029897 T AT03029897 T AT 03029897T AT E319430 T1 ATE319430 T1 AT E319430T1
Authority
AT
Austria
Prior art keywords
desmopressin
preparing
dosage form
oral dosage
solid oral
Prior art date
Application number
AT03029897T
Other languages
English (en)
Inventor
Kristin Wannerberger
Hans Dr Lindner
Lars-Erik Olsson
Ann Elisabeth Svensson
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34560171&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE319430(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of ATE319430T1 publication Critical patent/ATE319430T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT03029897T 2003-12-29 2003-12-29 Verfahren zur herstellung einer festen oralen dosierungsform von desmopressin ATE319430T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03029897A EP1550439B1 (de) 2003-12-29 2003-12-29 Verfahren zur Herstellung einer festen oralen Dosierungsform von Desmopressin

Publications (1)

Publication Number Publication Date
ATE319430T1 true ATE319430T1 (de) 2006-03-15

Family

ID=34560171

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03029897T ATE319430T1 (de) 2003-12-29 2003-12-29 Verfahren zur herstellung einer festen oralen dosierungsform von desmopressin

Country Status (11)

Country Link
EP (1) EP1550439B1 (de)
AR (1) AR047155A1 (de)
AT (1) ATE319430T1 (de)
DE (1) DE60303872T2 (de)
DK (1) DK1550439T3 (de)
ES (1) ES2254858T3 (de)
IL (3) IL202881A0 (de)
NO (1) NO20045657L (de)
PT (1) PT1550439E (de)
SI (1) SI1550439T1 (de)
TW (1) TWI282284B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2007098945A2 (en) * 2006-03-02 2007-09-07 Ferring International Center S.A. Stable solid dosage form comprising desmopressin
SE0600482L (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
ES2756706T3 (es) 2008-05-21 2020-04-27 Ferring Bv Desmopresina bucodispersable para aumentar el periodo inicial de sueño ininterrumpido por nocturia
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1677095A (en) * 1994-01-11 1995-08-01 Alkermes Controlled Therapeutics, Inc. Oral dosage form of desmopressin (ddavp)
US20030091637A1 (en) * 2001-10-15 2003-05-15 Hans-Ulrich Petereit Use of a copolymer to prepare a pharmaceutical form that contains a peptide of protein as active principle
CA2484724C (en) * 2002-05-07 2007-01-16 Ferring B.V. Pharmaceutical formulations

Also Published As

Publication number Publication date
DE60303872T2 (de) 2006-10-19
SI1550439T1 (sl) 2006-08-31
NO20045657D0 (no) 2004-12-27
AR047155A1 (es) 2006-01-11
ES2254858T3 (es) 2006-06-16
DK1550439T3 (da) 2006-04-03
IL189107A0 (en) 2008-06-05
EP1550439B1 (de) 2006-03-08
IL165780A0 (en) 2006-01-15
TW200528141A (en) 2005-09-01
TWI282284B (en) 2007-06-11
NO20045657L (no) 2005-06-30
PT1550439E (pt) 2006-06-30
IL202881A0 (en) 2011-07-31
DE60303872D1 (de) 2006-05-04
EP1550439A1 (de) 2005-07-06
HK1079696A1 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
ATE447942T1 (de) Verfahren zur herstellung einer gegen missbrauch gesicherten darreichungsform
DE602004022485D1 (de) Verfahren zur Herstellung einer Klemmbackenanordnung
EP1726599A4 (de) Verfahren zur herstellung von fluorpolymer
DE60212118D1 (de) Verfahren zur Herstellung einer Kreuzschienenstruktur von Nanodrähten
DE60302682D1 (de) Verfahren zur Herstellung von Nanopartikeln
ATE515500T1 (de) Verfahren zur herstellung von telmisartan
DE60320527D1 (de) Verfahren zur herstellung von grünteepolyphenol
DE60328522D1 (de) Verfahren zur herstellung von bisphenol
ATA11912002A (de) Verfahren zur herstellung von fälschungssicheren identifikationsmerkmalen
DE60317690D1 (de) Verfahren zur herstellung von valsartan
DE60304119D1 (de) Verfahren zur Herstellung von dünnwandigen gleichartigen Gitterstrukturen
DE502004012455D1 (de) Verfahren zur Herstellung einer Lötstoppbarriere
ATE308524T1 (de) Verfahren zur herstellung von aripiprazole
DE50311721D1 (de) Verfahren zur Herstellung von Aryl-aminopropanolen
DE502004004318D1 (de) Verfahren zur herstellung von metall-matrix-verbundwerkstoffen
ATE460414T1 (de) Verfahren zur herstellung von tiotropiumsalzen
DE50303611D1 (de) Verfahren zur herstellung von polyisobuten
ATE319430T1 (de) Verfahren zur herstellung einer festen oralen dosierungsform von desmopressin
DE502004003171D1 (de) Verfahren zur herstellung von bauteilen einer gastubine
DE602004028385D1 (de) Verfahren zur herstellung von bisphenol a
ATE402138T1 (de) Verfahren zur herstellung von 2- aminoindanderivaten
ATE352573T1 (de) Verfahren zur herstellung von copolymerisaten
ATE471941T1 (de) Verfahren zur herstellung von thiazolopyrimidinen
DE602004005239D1 (de) Verfahren zur herstellung von tubulininhibitoren
DE60301444T2 (de) Verfahren zur Herstellung von Polyalkylphenoxyaminoalkanen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1550439

Country of ref document: EP